Saturday, 31 October 2026European Markets

KOMPLETT BANK Stock Is 11% Up So Far On Tuesday

Loading stream...

(VIANEWS) - Shares of KOMPLETT BANK (Oslo Børs Benchmark Index_GI: KOMP.OL) rose by a staggering 11.49% to kr5.24 at 11:38 EST on Tuesday, following the last session's downward trend. Oslo Børs Benchmark Index_GI is sliding 0.49% to kr1,213.86, following the last session's upward trend. This seems, up to now, a somewhat down trend exchanging session today.

KOMPLETT BANK's last close was kr4.70, 38.16% under its 52-week high of kr7.60.

About KOMPLETT BANK

Komplett Bank ASA provides unsecured financing to private individuals in the Norwegian, Finland, Sweden, and German markets. It offers deposit products, consumer loans, credit cards, and point of sale finance products. Komplett Bank ASA was incorporated in 2012 and is headquartered in Lysaker, Norway.

Earnings Per Share

As for profitability, KOMPLETT BANK has a trailing twelve months EPS of kr-0.07.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 0.05%.

Volatility

KOMPLETT BANK's last week, last month's, and last quarter's current intraday variation average was 0.11%, 0.12%, and 1.56%.

KOMPLETT BANK's highest amplitude of average volatility was 0.75% (last week), 1.00% (last month), and 1.56% (last quarter).

Volume

Today's last reported volume for KOMPLETT BANK is 66664 which is 40.05% below its average volume of 111201.

More news about KOMPLETT BANK (KOMP.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com